Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$346,424
-$35,728 QoQ
Shares Held
2,742
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,577
of 2,266 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. GILD ranks #5 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,905 | $17,842,534 | |
| 2 | LLY |
ELI LILLY & Co
|
12,084 | $14,493,913 | |
| 3 | JNJ |
Johnson & Johnson
|
23,321 | $5,922,834 | |
| 4 | NVO |
Novo Nordisk A S
|
113,575 | $5,444,785 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
2,742 | $346,424 | |
| 6 | AZN |
Astrazeneca PLC
|
1,412 | $267,743 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,014 | $258,799 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,424 | 2,742 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $382,152 | 2,742 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $306,850 | 2,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $278,499 | 2,509 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $321,523 | 2,900 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $324,945 | 2,900 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $267,873 | 2,900 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $217,984 | 2,600 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $259,232 | 3,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $239,808 | 3,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $246,624 | 3,200 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $265,504 | 3,200 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $274,720 | 3,200 | Shares | Sole | 2023-03-24 | |
| 2021-12-31 | $232,352 | 3,200 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $244,475 | 3,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $241,010 | 3,500 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $226,205 | 3,500 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $203,910 | 3,500 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $230,643 | 3,650 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $280,831 | 3,650 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $272,874 | 3,650 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||